Statins reduce oxidized low-density lipoprotein levels, but do not alter soluble intercellular cell-adhesion molecule-1 and vascular cell-adhesion molecule-1 levels in subjects with hypercholesterolaemia.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical science

• Publication date

  2004-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1042/CS20030291PMID 12967321
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia.

  2003cited by this paper
• Simvastatin Reduces the Expression of Adhesion Molecules in Circulating Monocytes From Hypercholesterolemic Patients

  2003cited by this paper
• Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells.

  1997cited by this paper

• Alterations in LDL and HDL after an ischemic stroke associated with carotid atherosclerosis are reversed after 1 year

  2024cites this paper
• Pravastatin for lowering lipids.

  2020cites this paper
• Association between albumin and C‐reactive protein and ankle‐brachial index in haemodialysis

  2018cites this paper
• The synergistic effect of vascular cell adhesion molecule-1 and coronary artery disease on brain-derived neurotrophic factor.

  2017cites this paper
• An In Vitro Cynomolgus Vascular Surrogate System for Preclinical Drug Assessment and Human Translation

  2015cites this paper
• Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation

  2015cites this paper
• Hypolipidaemic and anti-inflammatory effects of fixed dose combination of atorvastatin plus ezetimibe in Indian patients with dyslipidaemia.

  2013cites this paper
• In Vitro and In Vivo Effects of Statins on Platelet-Activating Factor and Its Metabolism

  2011cites this paper
• Estudo da atividade inflamatória e plaquetária em pacientes com doença arterial coronária estável, submetidos a tratamento com duas estratégias hipolipemiantes intensivas: sinvastatina 80 mg e ezetimiba 10 mg/sinvastatina 20 mg

  2010cites this paper
• Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.

  2008cites this paper
• Leukocyte and endothelial adhesion molecules in patients with hypercholesterolemia: the effect of atorvastatin treatment.

  2008cites this paper
• Measurement of malondialdehyde (MDA) level in rat plasma after simvastatin treatment using two different analytical methods

  2008cites this paper
• The Effect of Aggressive Versus Conventional Lipid-lowering Therapy on Markers of Inflammatory and Oxidative Stress

  2007cites this paper
• Cerivastatin reduces cytokine-induced surface expression of ICAM-1 via increased shedding in human endothelial cells.

  2007cites this paper
• Factors Associated with Findings of Published Trials of Drug–Drug Comparisons: Why Some Statins Appear More Efficacious than Others

  2007cites this paper
• Circulating markers of endothelial function in cardiovascular disease.

  2006cites this paper
• Efecto de las estatinas más allá del colesterol

  2006cites this paper
• Beneficial effect of simvastatin treatment on LDL oxidation and antioxidant protection is more pronounced in combined hyperlipidemia than in hypercholesterolemia.

  2006cites this paper
• Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease.

  2005cites this paper
• Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia

  2005cites this paper
• New nonlipid effects of statins and their clinical relevance in cardiovascular disease

  2004cites this paper